GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (OTCPK:CVALF) » Definitions » EV-to-EBITDA

Covalon Technologies (Covalon Technologies) EV-to-EBITDA : -4.73 (As of May. 01, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Covalon Technologies EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Covalon Technologies's enterprise value is $17.15 Mil. Covalon Technologies's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-3.63 Mil. Therefore, Covalon Technologies's EV-to-EBITDA for today is -4.73.

The historical rank and industry rank for Covalon Technologies's EV-to-EBITDA or its related term are showing as below:

CVALF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -1779.96   Med: -7.13   Max: 1357.3
Current: -4.38

During the past 13 years, the highest EV-to-EBITDA of Covalon Technologies was 1357.30. The lowest was -1779.96. And the median was -7.13.

CVALF's EV-to-EBITDA is ranked worse than
100% of 468 companies
in the Biotechnology industry
Industry Median: 9.155 vs CVALF: -4.38

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-01), Covalon Technologies's stock price is $0.765. Covalon Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.148. Therefore, Covalon Technologies's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Covalon Technologies EV-to-EBITDA Historical Data

The historical data trend for Covalon Technologies's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Covalon Technologies EV-to-EBITDA Chart

Covalon Technologies Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.91 -7.30 29.30 -6.08 -6.57

Covalon Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.51 -8.73 -8.20 -6.57 -3.93

Competitive Comparison of Covalon Technologies's EV-to-EBITDA

For the Biotechnology subindustry, Covalon Technologies's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Covalon Technologies's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Covalon Technologies's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Covalon Technologies's EV-to-EBITDA falls into.



Covalon Technologies EV-to-EBITDA Calculation

Covalon Technologies's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=17.154/-3.629
=-4.73

Covalon Technologies's current Enterprise Value is $17.15 Mil.
Covalon Technologies's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Covalon Technologies  (OTCPK:CVALF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Covalon Technologies's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.765/-0.148
=At Loss

Covalon Technologies's share price for today is $0.765.
Covalon Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.148.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Covalon Technologies EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Covalon Technologies's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Covalon Technologies (Covalon Technologies) Business Description

Traded in Other Exchanges
Address
1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops advanced wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts, and sales.